Top Story

FDA approves Viekira Pak for treatment of HCV

December 19, 2014

The FDA today approved a treatment for patients with hepatitis C virus genotype 1 infection, including those with cirrhosis, according to a press release.

A combination of ombitasvir, paritaprevir and ritonavir tablets with dasabuvir tablets (Viekira Pak, AbbVie) is the fourth chronic HCV drug product the FDA has approved in the past 14 months, and the 11th drug to have previously received the FDA’s breakthrough therapy designation. It can be used with or without ribavirin, but is not recommended for patients with decompensated cirrhosis.

Clinical setbacks integral to long-term success in HCV treatment

December 19, 2014
In a new report, the Pharmaceutical Research and Manufacturers of America examined the successes and failures of hepatitis C virus infection research and therapies since…

CMS releases new quality of care data on physicians, ACOs, hospitals

December 19, 2014
CMS released new data on the quality of care provided by physician group practices, hospitals and Accountable Care Organizations, according to the CMS Blog.Included in…
Liver fibrosis, cirrhosis progressed faster in patients with HCV In the Journals

Liver fibrosis, cirrhosis progressed faster in patients with HCV

December 19, 2014
Veterans positive for hepatitis C virus infection were more likely to be diagnosed with liver fibrosis or cirrhosis after seroconversion compared with those who were…
In the Journals

High AKR1B10 protein expression showed promising survival rates for HCC

December 18, 2014
Among a cohort of Korean patients with hepatocellular carcinoma, high aldo-keto reductase 1B10 protein expression predicted longer recurrence-free and disease-specific…
More News Headlines »
CME
HCV Consults: Volume 1, Number 2

HCV Consults: Volume 1, Number 2

This activity is supported by educational grants from AbbVie and Genentech.

Approved interferon-free therapy has already become entrenched among clinicians for patients with HCV genotypes 2 and…
More »
Meeting News Coverage Video
thumbnail for video 3895262652001

Early liver transplantation could improve survival rates for patients with alcoholic hepatitis

November 17, 2014
BOSTON — Ibrahim A. Hanouneh, MD, hepatologist at Cleveland Clinic, discussed results of a study that compared…
More »
CME
HBV

Critical Issues in HBV
HBV Management in Complex Populations: Volume 1, Number 2

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »